<DOC>
	<DOCNO>NCT00188084</DOCNO>
	<brief_summary>Adult acute lymphoblastic leukemia treatment approach relie risk stratification , include cytogenetics . We want study diagnosis several blast cell parameter freeze sample GRAALL protocol enrol patient : 1 . A CD45-DNA double staining analyse flow cytometry allow mesurement blastic clone DNA ploidy , percentage cell S-phase , CD45 fluorescence index . 2 . The proteine P16 metabolic way , involve cell cycle regulation , study Western Blot analysis . The comparison parameter , main haematological data , follow prognostic analysis , base blast corticosensibility vivo , chimiosensibility , complete remission , survival . Combination study parameter allow appreciate clonal diversity . This help predict , diagnosis , high probability resistance treatment .</brief_summary>
	<brief_title>Description Prognostic Evaluation Four Biological Parameters Blast Cells Adult Acute Lymphoblastic Leukemia</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia , Lymphoid</mesh_term>
	<criteria>All GRAALL 2003 2005 enrol patient available frozen blast cell</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>59 Years</maximum_age>
	<verification_date>September 2005</verification_date>
</DOC>